American Academy of Pediatrics. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. Pediatrics. 1996;97:590-594.
American Cancer Society. Cancer Facts & Figures 2016. Atlanta, Ga: American Cancer Society; 2016.
American Cancer Society. Cancer Facts & Figures 2017. Atlanta, Ga: American Cancer Society; 2017.
American Joint Committee on Cancer. Testis. In: AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010:469-473.
Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers. Accessed at www.survivorshipguidelines.org/ on 11/20/14.
Honecker F, Wermann H, Mayer F, et al. Microsatellite instability, mismatch repair deficiency and BRAF mutation in treatment resistant germ cell tumors. J Clin Oncol. 2009;27:2129-2136.
Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet. 2006;367:754-765.
Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
Kanetsky P, Mitra N, Vardhanabhuti S, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet. 2009;41:811-815.
McMaster M, Feuer EJ, Tucker MA. New Malignancies Following Cancer of the Male Genital Tract. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (eds). New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute. NIH Publ. No. 05-5302. Bethesda, MD, 2006. Accessed on 4/18/2014 at http://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdf.
National Cancer Institute. Physician Data Query (PDQ). Testicular Cancer Treatment. 7/11/2014. Accessed at www.cancer.gov/cancertopics/pdq/treatment/testicular/HealthProfessional on January 15, 2015.
National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Testicular Cancer. Version 1.2015. Accessed at www.nccn.org/professionals/physician_gls/pdf/testicular.pdf on December 9, 2015.
Olofsson SE, Tandstad T, Jerkeman M, et al. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: A report from the Swedish-Norwegian Testicular Cancer Group. J Clin Oncol. 2011;29:2032-2039.
Pagliaro LC, Logothetis CJ. Cancer of the testis. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th edition. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015:988-1004.
Richiardi L, Scélo G, Boffetta P, et al. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer. 2007;120:623-631.
Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2020;70(4). doi:10.3322/caac.21591. Accessed at https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21591 on June 9, 2020.
Ryan CJ, Small EJ, Torti FM. Testicular cancer. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1713-1744.
Skolarus TA, Bhayani SB, Chiang HC, et al. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol. 2008;22:1485-1489.
Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97:1354-1365.
Turnbull C, Rapley EA, Seal S, et al; UK Testicular Cancer Collaboration. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010;42:604-607.